ClinicalTrials.govpublic full text
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
acute myeloid leukemia, hematopoietic and lymphoid system neoplasm, myelodysplastic syndrome, myeloproliferative neoplasm, recurrent acute myeloid leukemia, refractory acute myeloid leukemia, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1030036
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.